# Nucleus RadioPharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nucleus-radiopharma

- Industry: Healthcare
- Headquarters: Davidson, US
- Website: www.nucleusrad.com/
- Total disclosed funding: $62M
- Latest round: Series A (Jun 5, 2024)
- Investors on record: 10

## About

Based in New York, US, and founded by Eclipse Ventures and Mayo Clinic in collaboration, in 2022, Nucleus RadioPharma, Inc. operates as a healthcare platform that helps patients treat cancer through radiopharmaceuticals. In April 2026, Nucleus RadioPharma, Inc. raised USd 50 million in venture funding from OrbiMed Advisors.

The company is working on radiopharmaceuticals for cancer patients by developing technologies for radiopharmaceutical clinical development, manufacturing, and supply chain. Radiopharmaceuticals have been an effective treatment tool across a variety of cancer types but it has inefficiencies across the development, manufacturing, and supply chain as of October 2022. Hence the firm aims to bring radiopharmaceutical treatments to the market at a cost, scale, and efficacy that would have maximal impact.

The company will use the April 2026 funding to expand manufacturing capacity at its Rochester facility and begin construction of a second manufacturing site outside Philadelphia.

## Funding rounds

- Series A, Jun 5, 2024 — Mayo Clinic Ventures, AstraZeneca, Mercy Health, GE Healthcare, Echo Global Logistics, Inc., Eclipse Ventures, Granger Management, University of Missouri, Fox Chase Cancer Center
- Series A, Oct 17, 2023, $56M — Mayo Clinic Ventures, GE Healthcare, Echo Global Logistics, Inc., Bon Secours Mercy Health, Eclipse Ventures, Granger Management, University of Missouri
- Seed, Oct 12, 2022, $6M — Mayo Clinic Ventures, Eclipse Ventures

## Investors

- Mayo Clinic Ventures (https://capitalatlas.ai/funds/mayo-clinic-ventures) — Seed, Series A
- Eclipse Ventures (https://capitalatlas.ai/funds/eclipse-ventures) — Seed, Series A
- GE Healthcare — Series A
- Echo Global Logistics, Inc. — Series A
- Bon Secours Mercy Health — Series A
- Granger Management (https://capitalatlas.ai/funds/granger-management) — Series A
- University of Missouri — Series A
- AstraZeneca — Series A
- Mercy Health — Series A
- Fox Chase Cancer Center — Series A